Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3303551 | Gastrointestinal Endoscopy | 2014 | 21 Pages |
Abstract
By using best available estimates of the malignant potential of BE, endoscopic surveillance of patients with non-dysplastic BE is unlikely to be cost-effective for the majority of patients and depends heavily on progression rates between dysplasia grades. However, strategies that modify surveillance according to cancer risk might be cost-effective, provided that high-risk individuals can be identified and prioritized for surveillance.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Louisa G. PhD, George C. PhD, Nicholas G. MHealthEcon, Timothy MBBS, PhD, David C. MBBS, PhD, Australian Cancer Study Clinical Follow-Up Study Australian Cancer Study Clinical Follow-Up Study, David I. MBBS, PhD,